Central Sleep Apnea

Highmark Adds Coverage for Remedē System in Patients with Central Sleep Apnea

Highmark Blue Cross Blue Shield and its affiliates will provide coverage for the Respicardia Inc's remedē System implantable therapy for central sleep apnea, effective immediately.

Central Sleep Apnea

Primary Central Sleep Apnea Is Still a Mystery

But a new retrospective population-based study finds higher-than-expected frequencies of death, dementia, and arrhythmias.

Central Sleep Apnea

Itamar WatchPAT One Fully Disposable Home Sleep Test

Sleep diagnostics company Itamar Medical Ltd has received 510(k) clearance from the US Food and...

Genetic Study: Shared Molecular Pathway Might Influence Susceptibility to Lack of Oxygen Caused by Sleep-disordered Breathing and Other Lung Illnesses

Oct 29, 2019 | Central Sleep Apnea, Genes, Obstructive Sleep Apnea

Researchers have identified 57 genetic variations of a gene strongly associated with declines in...

Positive Airway Pressure Therapies for Sleep-Disordered Breathing in Heart Failure

Aug 5, 2019 | Central Sleep Apnea, CPAP & PAP Devices, Heart, Obstructive Sleep Apnea, Resource Center, Webinars

The presentation by Salma Patel, MD, MPH, discusses a recent study in the Journal of Respiratory...

Treatment Benefits of Remedē System Sustained Through 36 Months in Patients with Central Sleep Apnea

Jul 12, 2019 | Central Sleep Apnea, Neurostimulators

Newly published results from 24- and 36-month data from the remed? System Pivotal Trial...

Sleep Apnea: Why You Feel Tired After a Full Night of Sleep

Jun 19, 2019 | Central Sleep Apnea, Curated, Obstructive Sleep Apnea

CNET’s guide goes over the different types of sleep apnea, causes, risk factors, and symptoms to help people understand sleep apnea. The most common symptom of sleep apnea is snoring, but snoring on its own isn’t...

Therapy Update: Implanted Neurostimulators for Sleep Apnea

May 27, 2019 | Central Sleep Apnea, Emerging Technology, Neurostimulators, Obstructive Sleep Apnea, Therapy Devices

Inspire Medical, Respicardia, LivaNova, and Nyxoah share the latest data on their devices.

Sleep Apnea Being Diagnosed More Often as Awareness Spreads

May 20, 2019 | Central Sleep Apnea, Curated, Obstructive Sleep Apnea

Srinivasan Devanathan, medical director of Parkview Health Sleep Centers, said that sleep apnea is a prevalent disorder and is getting diagnosed more and more each year because people are more aware of it, reports KPC News....

Diagnosis and Management of Sleep Apnea in Cardiology Patients [On Demand Webinar]

May 13, 2019 | Central Sleep Apnea, Heart, Obstructive Sleep Apnea, Sleep & the Body, Webinars

The webinar Diagnosis and Management of Sleep Apnea in Cardiology Patients, produced by Sleep...

Analyzing ASV in People with Heart Failure and Sleep-disordered Breathing

Apr 15, 2019 | Central Sleep Apnea, Heart, Obstructive Sleep Apnea, Ventilation Therapies - ASV

New insights from the CAT-HF trial show promise for subsets of patients who use adaptive...

Itamar Launches Next Generation WatchPAT Home Sleep Test

Mar 21, 2019 | Central Sleep Apnea, Home Apnea Testing, Obstructive Sleep Apnea

Itamar Medical Ltd has launched the WatchPAT 300, the next generation of its WatchPAT system for...

Study Finds Significant Differences in How Various ASV Devices Treat Complex Sleep Apnea

Mar 19, 2019 | Central Sleep Apnea, Heart, Obstructive Sleep Apnea, Ventilation Therapies - ASV

Adaptive servo ventilation (ASV) is an effective treatment option for patients with complex sleep...

Integer Supports Respicardia’s Commercialization in Central Sleep Apnea Market Through New Agreements

Jan 16, 2019 | Central Sleep Apnea, Neurostimulators

Integer, a leading medical device outsource manufacturer, has entered into a new development agreement and a new supply agreement with Respicardia Inc. Under the agreements, Integer will be Respicardia’s development partner and...

CPAP Sanitizer Healthcare Startup Grows 2,805 Percent In 7 Years

Dec 28, 2018 | Central Sleep Apnea, CPAP & PAP Devices, Curated

The world’s first automated CPAP cleaner and sanitizer is experiencing growing demand. There are more than 8 million CPAP users in the United States, according to SoClean CEO Bob Wilkins, and their numbers are increasing by 8 to...